Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Health Service, United Kingdom | OTHER_GOV |
| British Lung Foundation | OTHER |
| University College, London | OTHER |
| University of Oxford |
Not provided
Not provided
Not provided
Not provided
The aim of this feasibility study is to identify the acceptability of an intervention designed to promote physical activity following pulmonary rehabilitation for individuals with Chronic Obstructive Pulmonary Disease (COPD). Participants in the intervention group will be provided with pedometers and step diaries and added to a WhatsApp group with other graduates of pulmonary rehabilitation for 52 weeks.
Evidence suggests that physical activity is not maintained following pulmonary rehabilitation for individuals with COPD. Peer social support, feedback about physical progression and recognition of opportunities to stay active following pulmonary rehabilitation have been identified as facilitators to physical activity following pulmonary rehabilitation. The proposed feasibility study has incorporated these factors into the intervention.
This is a mixed-methods study including a feasibility cluster randomised controlled trial and a qualitative process evaluation. Clusters will be pulmonary rehabilitation programmes across Lincolnshire Community Health Services, NHS Trust (n=8), randomly allocated to the Intervention or Control. Patients in the Intervention group will receive a multi component intervention following pulmonary rehabilitation (pedometer, step diary and WhatsApp) and patients in the Control group will receive standard care following pulmonary rehabilitation.
The primary objective is to identify and report the acceptability of the intervention for patients. The secondary objectives are to: 1) gather information on recruitment and consent rates of patients who are eligible and willing to participate, and to monitor retention of participants throughout the study; 2) understand the patients' and health care professionals' experience and views of the intervention and research procedures; 3) identify and report intervention fidelity throughout the study; 4) provide an estimate of likely changes in the proposed primary outcome for the full randomised controlled trial (average daily step count at 52 weeks following pulmonary rehabilitation) and other secondary health outcomes; 5) obtain the necessary statistical parameters to inform sample size calculations in a future definitive cluster randomised controlled trial. The results from the feasibility study will inform the design of a definitive trial, including whether the specific intervention has the potential to promote physical activity.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| WhatsApp, Pedometer and Step Diary | Experimental | Pedometer, step diary and WhatsApp following pulmonary rehabilitation |
|
| Control | No Intervention | Usual care following pulmonary rehabilitation. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| WhatsApp, Pedometer and Step Diary | Behavioral | Participants will be provided with a daily step diary and added to a group chat on WhatsApp. The group chat will be populated by other members of pulmonary rehabilitation programme (cluster) and the WhatsApp group leader will encourage participants to keep active. Participants will be encouraged to record the number of steps walked in a paper diary at the end of each day (i.e. prior to bedtime). This diary will simply have three columns: day of the week; number of steps; comments (optional). The intervention will last 52 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| Acceptability of the intervention | The number of patients who comply with the intervention will be measured | 55 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment rates | The time taken to achieve planned sample size (clusters, participants) will be measured | Up to 26 weeks (approximately) |
| Consent rates | The number of eligible patients willing to consent to take part in the study will be measured |
Not provided
Inclusion Criteria:
Cluster level
Patient level
Patients (for telephone interviews)
Health care professionals
WhatsApp group leaders
Exclusion Criteria:
Cluster level
Patient level
Patients (telephone interviews)
Health care professionals
WhatsApp group leaders
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hayley Robinson, MSc | University of Lincoln | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| NHS pulmonary rehabilitation clinics across Lincolnshire | Lincoln | Lincolnshire | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
Physiotherapists will be aware of the allocation of the programmes (not possible to blind) as they will be involved with delivering information/training of the intervention components. However, a researcher blinded to group allocation will perform the quantitative analysis.
|
| Up to 26 weeks (approximately) |
| Attrition rates | The number of patients who withdraw from the study will be measured | Up to 55 weeks (study completion) |
| Semi-structured telephone interviews with subsets of patients | Patients' experience/views of the research procedures and intervention will be measured | At relevant intervals up to 55 weeks (study completion) |
| Focus groups with health care professionals | Healthcare professionals' experience/views of the research procedures and intervention will be measured | At relevant intervals up to 55 weeks (study completion) |
| Content of anonymised WhatsApp chat | The WhatsApp chats will be sent to the research team to measure intervention fidelity. | At 4 week intervals, up to 55 weeks (study completion) |
| WhatsApp Checklist | The WhatsApp checklists will be sent to the research team to measure the intervention fidelity. | At 4 week intervals, up to 55 weeks (study completion) |
| Step diary (self-reported) | Patients' step diaries will be collected to assess the intervention fidelity. | 55 weeks (study completion) |
| Activity levels | Activity levels will be measured by an activity monitor (Actigraph wGT3X-BT). Physical activity will be specified for:
| During pulmonary rehabilitation (baseline), 12 and 52 weeks after pulmonary rehabilitation |
| PROactive tool | The PROactive tool measures both physical activity amount (from the activity monitor) and physical activity difficulty to compute a reliable measure of physical activity in COPD. | During pulmonary rehabilitation (baseline); 12 and 52 weeks after pulmonary rehabilitation |
| Sleep levels | Sleep will be measured by an activity monitor (Actigraph wGT3X-BT). Sleep will be specified for:
| Baseline, 12 and 52 weeks after pulmonary rehabilitation |
| Sleep (self-reported sleep habits) | In conjunction with wearing an activity monitor, participants will report the:
| During pulmonary rehabilitation (baseline), 12 and 52 weeks after pulmonary rehabilitation |
| Incremental Shuttle Walk Test (ISWT) | The ISWT will measure participants functional capacity. | During pulmonary rehabilitation (baseline), 12 and 52 weeks after pulmonary rehabilitation |
| Chronic Respiratory Questionnaire (CRQ) | The CRQ will measure patients' disease specific quality of life. | During pulmonary rehabilitation (baseline); 12 and 52 weeks after pulmonary rehabilitation |
| Hospital Anxiety and Depression Scale (HADS) | HADS will measure patients' psychological well-being. | During pulmonary rehabilitation (baseline); 12 and 52 weeks after pulmonary rehabilitation |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |